This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Tim Wilsdon is a panelist during the session titled “Access to Oncology Combinations – the ‘Combination Challenge.'”
Michele Pistollato is presenting two posters during the conference. The first explores novel evidence on the consequences of increased net price transparency in Europe. The second looks at the challenges bringing oncology combinations to market, and their solutions. Both research projects were funded by MSD.
For more information on this event, click here.
The report finds that NCCPs rarely specify the funds that need to be committed or the spending that occurs in practice. When evidence of funding impact is...
Similarly, with a Republican majority in the US House and Senate, it is unknown what the legislative agenda for 2025 will look like and how the nation’s public...
